Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teva Pharmaceutical Industries Ltd. Director's Dealing 2021

Jun 16, 2021

7082_rns_2021-06-16_a64738a8-20c5-496d-aa64-667448a16b43.htm

Director's Dealing

Open in viewer

Opens in your device viewer

����� �� ����� ���� ���� false

��� ������ ��������� ��"� 2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954 10205
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 16/06/2021
www.isa.gov.il www.tase.co.il Reference: 2021-02-102081 Time of broadcast: 15:28 15:28

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on����� �� ����� ���� ����

FORM_4__ROSEMA_2021615_193141_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE Date of revision of form structure: 15/06/2021
Address: P.O.B 3190 , Petach Tikva 49131   , Tel: 03-9148262 , Fax: 03-9267519
E-mail address: [email protected]
Previous names of reporting entity:
Name of the Signatory: Bergwerk Dov Position of Signatory in the reporting corporation: Vice President & General Counsel Name of Employer Company:
Address: Basel 5 , Petach-Tikva 4951033 Telephone: 03-9267149 Facsimile: 03-9267429 E-mail: [email protected] 1